{"name":"Rinri Therapeutics","slug":"rinri-therapeutics","ticker":"","exchange":"","domain":"rinri.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPb0ktazBtTkJ3QWxybGtFTFFJb1N1aUhXX3BUbTFCQkpyd1pMSTdlZmhEUktWSldLRmhJV2t5SE84Zk9Za1F0THotODkxcHd5UkJYLV9nVXZHZ05Jd0lWVktBM284QWRnMHZyRy1ZY3NWMXpRUXp2TmhpME53SUhzTGgxTzMweHRRUnBzR2Y4QUVzUkxyWlpCY2E5b1F5bEVVdXhSanhBZW9Fbm5hT1pSSEF3aDhIUll2bXQwUS1FT18tMnNVS1d1TzlFSFl2OHVJcVFfdXlfdVkxU0U4YTFScVlMZjRlSTZKV0dRSDdB?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Hearing Loss Clinical Trial Pipeline Shows Potential with Active Contributions from 30+ Key Companies | DelveInsight - Barchart.com","headline":"Hearing Loss Clinical Trial Pipeline Shows Potential with Active Contributions from 30+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOaVFfdm1heXdheHFkZjBHYzRSTW5YSGQtUXZtS3Q2bEx2Y21YdFhsMU5nOU1fVHBxeGpDTHM2RHJ4NUtUVkE3dXFETTBhVHdHYkJNaVlyNnpQMjl0X2JTYmRxeDd1ZVk2Y1M3SDYyalBXM3FwZjNpTTljdnBlS2R6RlBINnZQLUxuYXVyc3lYUjNBSjdTTHgyUU1rT0V2ZGg5Zkl4dGZEMWU?oc=5","date":"2025-12-18","type":"pipeline","source":"fortune.com","summary":"This U.K. startup's AI platform could slash the cost of CAR-T therapy and other cell-based medicines - fortune.com","headline":"This U.K. startup's AI platform could slash the cost of CAR-T therapy and other cell-based medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxPMk1Rb0pjOUY4WXAtZTVRY0hWUFN1RzluZFVXcHBoMmhxaG45QktTZ2pkWnhYQjBKTWxkalFzbXQ0NE41N0lOVTB6UWZrUHh4ZTIzX1BYNUxqZHdSc0lHLWZWNjhGVjNQekJCeGZfLXE0X2syTUQ2UjZXOEloN25rOG9aeGdKV042UHV6NXJNR0tTRzRwSzBxRGlzMWtzQjJsOGt4bWt6Y1NkN25zUXpIc2ZscFZXQ3Z4YUJVMjdXUG85RWVzWkY5Q0ZaU2ZVM2lpSDF6RGh6c3V1cjRlckNtd09OdDBoQlRRWDY3cWhJdUliMEFnU2lKMEFoMXVLOUtMNU1LNGMydm40TEZaeVBpMGxLWWJvbk5rS1hIYzg2VWVraW43a3BQbFlLZ25zRkpZakdDTg?oc=5","date":"2025-08-11","type":"regulatory","source":"Barchart.com","summary":"Hearing Loss Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Sensorion, Fennec Pharma, Sound Pharma, Decibel Therapeutics, Akouos - Barchart.com","headline":"Hearing Loss Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Sensorion, Fenn","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-07-02","type":"regulatory","source":"Express Pharma","summary":"First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved - Express Pharma","headline":"First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1pbHdxZ2JvWk9tVkM3R3d0VThNTzJHQUhVanUxYU0xeFNUemF4WnJ1THdoWl90ZkxMSngwOHpHXzRFZ01rZnFIelM1UWlocXU3R2VROVR3aGFyQklUdHhMRWFNYm1pNnVXWHVveDlkMjJnLXkzbEktVExCNA?oc=5","date":"2025-03-19","type":"pipeline","source":"pharmaphorum","summary":"5th Inner Ear Disorders Therapeutics Summit - pharmaphorum","headline":"5th Inner Ear Disorders Therapeutics Summit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQUDZ6dFZ2eW5wVzBNRXctS1lsNnBCU2Z4Q2YxRDdWaU5JVXR2MU5xTDFyZUIwX1ViWUl0d0V6MkQtekhlRFkzM2lmYXpHR09Fd1MwSEVmdUlPU0FhYnpyVjVaT3VrbVN5aWs3N2EwRDBmb19xOUhES1QyS29Ec09BbVlwVGFzZ3BiV1FQTnktXzJhT25CWHNBeGtvR3NxMXZnbDM3MllwS0NNQVFkcUNrX0VEOGhMWTFQMi0zaUVKbjA5dTRYMmNiOVFTLUUtb0YwSjg4REQ0TWJEcVkwQTltdGtBMUU3NkpOeUMzMWhYVWxyNUFBRXg3WXFIZm1NNnBodTdXQW94bFN6NlVfNTZtUVhQUFVjSVBGVVNzSWRRaXFCcFBlaXhLUg?oc=5","date":"2024-10-30","type":"trial","source":"globenewswire.com","summary":"Advancements in Sensorineural Hearing Loss Clinical Trial - globenewswire.com","headline":"Advancements in Sensorineural Hearing Loss Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQWXp0THo0M1Nlc3J1Q2FoVHgtZEdjVEhveFJjSDhROTNqdnlzZVlJd0lkblRndFQxRVZnNDN5TVZ4anA4RW1TNDlOUjJKU1dBbFhFT2xXcXRhMzF0eXNyTXRSOVgyNTJqNE1iNFUzMUtfdVFHT1k3azlFLXpraC1kaG1ELVk?oc=5","date":"2024-04-08","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Pharma and biotech hires from March 2024 - pharmaphorum","headline":"Changing Faces: Pharma and biotech hires from March 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOMUhjWVpFOEVITlpCSmUyNFNBVUZXOEN1OWxDdWxhVE4weklwX1hBaTh1MEgwNUNtaXpGWVNBWHJCVUczZFBxOGN5VHlJQ1FGQ1J5T2NJSDlWc2FHMUJSeW0tOU5tblpIWk4tQ1E2eHhCTkh2akFRei04cm1ST3BkVk0waVdZb2ZTcTBIRXJUNnJ5eTEyWUMtcV9iel9GVFNaYlcwaEFOX0g0YVBjX0JvNUtB?oc=5","date":"2023-08-11","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Regeneron’s All Ears for Hearing Loss Drug Developer - Genetic Engineering and Biotechnology News","headline":"StockWatch: Regeneron’s All Ears for Hearing Loss Drug Developer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}